CLASS I Drug recall · Reported 23 May 2018 · FDA Enforcement Report

Piperacillin and Tazobactam for Injection, USP* Single Use Vials recalled

Apotex is recalling Piperacillin and Tazobactam for Injection, USP* Single Use Vials per, distributed nationwide in the US. The recall was initiated on 8 May 2018 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLots: 502H001 Exp. 01/2019; 502H003, 502H004, 502H005, Exp. 04/2019; 502H009, 502H012, Exp. 05/2019.
Quantity recalled13453 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0840-2018
FDA event ID
80063
Recalling firm
Apotex, North York
Classification
Class I
Status
Terminated
Recall initiated
8 May 2018
FDA classified
5 Jun 2018
Reported
23 May 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay
Drug class
Antibiotics

Timeline

8 May 2018Recall initiated by company
23 May 2018Published in enforcement report+15 days
5 Jun 2018Classified by FDA+13 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: High Levels of Impurities Resulting in Decrease Potency

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Piperacillin and Tazobactam for Injection, USP 4.5 gram/vial* 10-count Single Use Vials per carton, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd. Irungattukottai-602 105, India Mfg. for: Apotex Corp. Weston, FL 33326. NDC 60505-0688-4

Where it was distributed

Nationwide in the USA.

Nationwide

Questions about this recall

Why was it recalled?

Subpotent Drug: High Levels of Impurities Resulting in Decrease Potency

Which lots are affected?

Lots: 502H001 Exp. 01/2019; 502H003, 502H004, 502H005, Exp. 04/2019; 502H009, 502H012, Exp. 05/2019.

Where was it sold?

Nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 80063
ReportedClassRecallCompanyReasonWhere
CLASS IPiperacillin and Tazobactam for Injection, USP* Single Use Vials recalledApotexPotency & AssayNationwide

More recalls from Apotex

All 76
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIParoxetine Extended-Release Tablets, 37.5mg recalled by ApotexParoxetine HydrochlorideApotexPotency & AssayNationwide
DrugCLASS IIPaxil CR, Paroxetine, Extended-Release Tablets, 37.5mg recalledApotexPotency & AssayNationwide
DrugCLASS IIDesmopressin Nasal Spray, USP, 10 mcg/ bottle (50 doses) recalledApotexOtherNationwide
DrugCLASS IIBrimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recalledBrimonidine Tartrate/timolol Maleate Ophthalmic SolutionApotexSterilityNationwide
DrugCLASS IIKetorolac Tromethamine Ophthalmic Solution recalled by ApotexKetorolac TromethamineApotexSterilityNationwide

Other Piperacillin recalls

All 17